US pharmaceutical company Eli Lilly and Company reported its results today, which beat expectations and $LLY-2.0% shares are up more than 15% in response. Fundamentals are quite solid and the stock is up over 40% for the year, which I like and since I see potential in healthcare and I like pharmaceutical and medical companies, I like this company even more :D. The stock may be up, but so is the price. If I decided to buy this stock, I would buy at $370 and below.
How do you view this company and do you have $LLY-2.0% stock included in your portfolio?
Eli Lilly
LLYOpen $811.87
Day range $801.30 - $821.99
52 week range $446.89 - $966.10
In Patria's coverage, there's one more link "Unexpectedly good quarterly numbers came together today with results from Novo Nordisk's clinical trial for rival Wegova. As Mounjaro is based on a similar principle (GLP-1/GIP analogue), its indication is expected to be extended to cardiovascular disease in the future as well."